1st Quarter - Report

FORBES-TATE for PHRMA

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to Rx Drug pricing; Issues related to IPAB; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act(Public Law 98-417). Issues related to H.R.965, S.340 CREATES Act of 2019; Issues related to the H.R. 985 FAST Generics Act of 2019.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 985 (116th), H.R. 965 (116th), S. 340 (116th)

Consumer Issues/Safety/Products CSP

Issues related to Direct to Consumer (DTC) Advertising.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues pertaining to Rx Drug pricing.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues pertaining to Rx Drug pricing.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.